BRIDGEBIO PHARMA INC (BBIO) Stock Earnings Estimates
NASDAQ:BBIO • US10806X1028
79.34 USD
+6.01 (+8.2%)
Last: Feb 12, 2026, 10:26 AM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 77.65M 11.37% | 9.303M -88.02% | 221.902M 2,285.27% | 508.33M 129.08% | 911.57M 79.33% | 1.57B 72.23% | 2.289B 45.80% | 3.126B 36.57% | 3.822B 22.26% | 4.537B 18.71% | 5.122B 12.89% | 5.444B 6.29% | |
| EBITDA YoY % growth | -461.66M 19.12% | -592.95M -28.44% | -571.293M 3.65% | -480.303M 15.93% | -239.87M 50.06% | 221.72M 192.43% | 146.88M -33.75% | 535.5M 264.58% | 934.32M 74.48% | 1.32B 41.28% | 1.646B 24.70% | 1.921B 16.71% | |
| EBIT YoY % growth | -468.43M 18.76% | -599.444M -27.97% | -577.368M 3.68% | -503.353M 12.82% | -276.515M 45.07% | 257.25M 193.03% | 767.55M 198.37% | 1.469B 91.39% | 2.009B 36.76% | 2.517B 25.29% | 2.996B 19.03% | 3.232B 7.88% | |
| Operating Margin | -603.26% | -6,443.56% | -260.19% | -99.02% | -30.33% | 16.39% | 33.53% | 46.99% | 52.56% | 55.48% | 58.49% | 59.37% | |
| EPS YoY % growth | -3.11 20.46% | -3.94 -26.69% | -3.09 21.57% | -3.53 -14.26% | -1.86 47.24% | 0.54 128.84% | 4.81 795.25% | 7.67 59.49% | 10.51 36.97% | 13.15 25.19% | 15.36 16.75% | 15.17 -1.20% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.73 47.68% | -0.70 20.89% | -0.58 38.71% | -0.49 48.46% | -0.34 52.96% |
| Revenue Q2Q % growth | 148.42M 2,423.29% | 166.24M 42.53% | 194.16M 75.61% | 221.48M 83.50% | 266.31M 79.43% |
| EBITDA Q2Q % growth | -90.494M 57.96% | -62.258M 39.27% | -39.749M 69.63% | -38.534M 70.89% | N/A |
| EBIT Q2Q % growth | -121.92M 44.92% | -105.638M -1.77% | -85M 36.32% | -67.61M 50.42% | -37.099M 69.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.95 13.64% | -0.91 | -0.04 | -4.81% |
| Q2 2025 Q2Q % growth | -0.95 -143.59% | -0.86 | -0.09 | -10.44% |
| Q1 2025 Q2Q % growth | -0.88 -340.00% | -0.94 | 0.06 | 6.56% |
| Q4 2024 Q2Q % growth | -1.40 -45.83% | -1.15 | -0.25 | -21.38% |
| Q3 2024 Q2Q % growth | -1.10 -1.85% | -1.00 | -0.10 | -10.20% |
| Q2 2024 Q2Q % growth | -0.39 60.20% | -1.09 | 0.70 | 64.07% |
| Q1 2024 Q2Q % growth | -0.20 78.26% | -0.78 | 0.58 | 74.34% |
| Q4 2023 Q2Q % growth | -0.96 -4.35% | -0.93 | -0.03 | -3.37% |
| Q3 2023 Q2Q % growth | -1.08 -16.13% | -0.83 | -0.25 | -29.83% |
| Q2 2023 Q2Q % growth | -0.98 -1,300.00% | -0.85 | -0.13 | -15.29% |
| Q1 2023 Q2Q % growth | -0.92 22.69% | -0.85 | -0.07 | -8.52% |
| Q4 2022 Q2Q % growth | -0.92 8.91% | -0.87 | -0.05 | -5.84% |
| Q3 2022 Q2Q % growth | -0.93 12.26% | -1.01 | 0.08 | 8.30% |
| Q2 2022 Q2Q % growth | -0.07 89.39% | -0.64 | 0.57 | 89.13% |
| Q1 2022 Q2Q % growth | -1.19 -0.85% | -1.13 | -0.06 | -5.11% |
| Q4 2021 Q2Q % growth | -1.01 | -0.89 | -0.12 | -14.11% |
| Q3 2021 Q2Q % growth | -1.06 -8.16% | -0.92 | -0.14 | -15.33% |
| Q2 2021 Q2Q % growth | -0.66 35.92% | -0.96 | 0.30 | 31.27% |
| Q1 2021 Q2Q % growth | -1.18 -51.28% | -0.75 | -0.43 | -56.60% |
| Q4 2020 Q2Q % growth | -1.01 | -0.87 | -0.14 | -16.65% |
| Q3 2020 Q2Q % growth | -0.98 | -0.94 | -0.04 | -4.43% |
| Q2 2020 Q2Q % growth | -1.03 | -0.79 | -0.24 | -30.80% |
| Q1 2020 Q2Q % growth | -0.78 | -0.68 | -0.10 | -13.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 120.7M 4,318.01% | 108.51M | 12.19M | 11.23% |
| Q2 2025 Q2Q % growth | 110.565M 4,999.86% | 93.238M | 17.327M | 18.58% |
| Q1 2025 Q2Q % growth | 116.633M -44.76% | 63.179M | 53.454M | 84.61% |
| Q4 2024 Q2Q % growth | 5.882M 237.08% | 3.549M | 2.333M | 65.74% |
| Q3 2024 Q2Q % growth | 2.732M -33.22% | 3.837M | -1.105M | -28.80% |
| Q2 2024 Q2Q % growth | 2.168M 32.11% | 3.641M | -1.473M | -40.46% |
| Q1 2024 Q2Q % growth | 211.12M 11,461.88% | 14.314M | 196.806M | 1,374.92% |
| Q4 2023 Q2Q % growth | 1.745M -6.68% | 6.353M | -4.608M | -72.53% |
| Q3 2023 Q2Q % growth | 4.091M 1,103.24% | 4.118M | -27K | -0.66% |
| Q2 2023 Q2Q % growth | 1.641M -97.77% | 3.053M | -1.412M | -46.25% |
| Q1 2023 Q2Q % growth | 1.826M 8.05% | 3.443M | -1.617M | -46.96% |
| Q4 2022 Q2Q % growth | 1.87M -85.49% | 4.615M | -2.745M | -59.48% |
| Q3 2022 Q2Q % growth | 340K -85.47% | 8.063M | -7.723M | -95.78% |
| Q2 2022 Q2Q % growth | 73.75M 36.52% | 16.389M | 57.361M | 350.00% |
| Q1 2022 Q2Q % growth | 1.69M 267.39% | 4.789M | -3.099M | -64.71% |
| Q4 2021 Q2Q % growth | 12.89M 10,641.67% | 22.009M | -9.119M | -41.43% |
| Q3 2021 Q2Q % growth | 2.34M -71.22% | 17.706M | -15.366M | -86.78% |
| Q2 2021 Q2Q % growth | 54.02M | 35.536M | 18.484M | 52.01% |
| Q1 2021 Q2Q % growth | 460K | 31.091M | -30.631M | -98.52% |
| Q4 2020 Q2Q % growth | 120K | 17.269M | -17.149M | -99.31% |
| Q3 2020 Q2Q % growth | 8.13M | 8.772M | -642K | -7.32% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.36% | 1.85% | 0.65% | 0.67% |
| Revenue | 2.59% | 0.29% | 0.63% | 2.58% |